Compare Tilray Brands Inc (TLRY) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tilray Brands Inc vs Wells Fargo & Co — how do they compare? Tilray Brands Inc trades at $3.54 (market cap $530.54M), while Wells Fargo & Co trades at $83.55 (market cap $248.06B). The key difference: Wells Fargo & Co is far larger — about 467.6× Tilray Brands Inc's market cap, and Wells Fargo & Co pays a 2.44% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Wells Fargo & Co for 88 Days on average.
| TLRY | WFC | |
|---|---|---|
Market Cap | $530.54M | $248.06B |
Volume | 9,099,075 | 16,615,741 |
Sector | Health | Financials |
52-Week High | $17.20 | $96.40 |
52-Week Low | $3.54 | $73.42 |
Typical Hold Time | 31 Days | 88 Days |
Enterprise Value | $684.46M | $503.91B |
Dividend Yield | — | 2.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.59, down 3.36% on the day and near 52-week lows, with a bearish technical signal. The company reported revenue of $821.31M for 2025 but posted a net loss of -$2.19B, missing earnings expectations for four consecutive quarters. While analyst consensus shows 70% hold ratings, the stock faces significant profitability challenges with negative margins and cash flow concerns despite some revenue growth projections.
The outlook remains challenging with persistent losses and negative cash flow, though the stock trades at discounted valuation multiples. Key risks include ongoing profitability struggles and cannabis regulatory uncertainty. Potential catalysts include upcoming Q1 2027 earnings on October 8, 2026, and potential marijuana reform developments that could benefit the company's positioning.
Wells Fargo (WFC) trades at $82.06, up 2.24% today, with a bearish technical signal but strong fundamentals including a P/E of 11.92 and net income margin of 25.97%. Recent earnings show a beat in Q2 2026 but misses in prior quarters. The company's credit rating was upgraded to 'A-' by S&P on October 1, 2026, reflecting improved risk management. Cash flow trends indicate volatility, with 2025 showing negative operating cash flow but positive projections for 2026.
The outlook for WFC is mixed; analyst consensus targets $99.13 with 47% buy ratings, suggesting upside potential, but technical indicators and recent earnings misses pose near-term risks. Key opportunities include dividend stability and rate hike benefits, while risks involve cash flow volatility and competitive pressures in the banking sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
